Forecasts data is unavailable for this security.
Consensus recommendation
- 17-Mar-22
- 15-Dec-22
- 19-Jan-23
- 16-Feb-23
- 16-Mar-23
Select bar for recommendation details.
Recommendations | 16-Mar-23 | |
---|---|---|
Buy | 4 | |
Outperform | 4 | |
Hold | 4 | |
Underperform | 0 | |
Sell | 0 |
Share price forecast in USD
The 11 analysts offering 12 month price targets for Hikma Pharmaceuticals Plc have a median target of 1,926.17, with a high estimate of 2,716.11 and a low estimate of 1,678.95. The median estimate represents a 13.34% increase from the last price of 1,699.50.
High | 59.8% | 2,716.11 |
Med | 13.3% | 1,926.17 |
Low | -1.2% | 1,678.95 |
Dividends in USD
Div growth (TTM) | -32.79% |
---|
More ▼
Earnings history & estimates in USD
Average growth rate | +7.40% |
More ▼
Revenue history & estimates in USD
Average growth rate | +5.08% |
More ▼